Ramesh Ramalingam
☆    

India,
2018-04-13 10:52

Posting: # 18679
Views: 1,402
 

 Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

Dear All,

Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT (oral Dispersible Tablet) BE study. Could any one please suggest the drug administration procedure for oral Dispersible Tablet in bioequivalence study (If product specific BE study recommendation not issued).

:confused:

Regards,
Ramesh.R:
jag009
★★★

NJ,
2018-04-13 21:23

@ Ramesh Ramalingam
Posting: # 18680
Views: 1,084
 

 Oral Dispersible Tablet BE study USFDA submission

Hi,

» Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT

I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...
anky1212
☆    

India,
2018-05-31 13:37

@ jag009
Posting: # 18831
Views: 641
 

 Oral Dispersible Tablet BE study USFDA submission

Hi,

We did such studies in which we had allowed subject to wet the mouth by swallowing 20 mL of water directly before placing the investigational product on the tongue. After placing tablet on tongue, subject was asked not to chew or crush the tablet and after 30 seconds mouth was checked. We did not provided water as PIL mentioned use of tablet with or without tablet.
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,490 posts in 4,135 threads, 1,335 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 14:04 CEST

Not to be absolutely certain is, I think,
one of the essential things in rationality.    Bertrand Russell

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5